Digital mammography ready for prime time

Is digital mammography ready for prime time? That was the question presenter J. Anthony Siebert, PhD, University of California (Davis) outlined last week in a session at the Healthcare Information Management and Systems Society meeting in Dallas.

The session took a close look at the pros and cons of digital, with Siebert predicting that the Digital Mammographic Imaging Screening Trial (DMIST) will show that digital and analog yield fairly comparable clinical results with digital adding value in other areas. That is, digital can overcome film limitations and increase efficiency, improve image quality and enable mammography PACS and CAD. The ability to deploy digital telemammography screening is a significant plus, Siebert said. Digital systems also support advanced applications such as digital tomosynthesis, dual-energy subtraction and breast CT.
   
On the downside, Siebert pointed to the high acquisition costs of digital, its somewhat lengthy learning curve, storage issues related to study sizes of up to 200 megabytes and the difficulties of operating in a hybrid soft- and hard-copy environment. Soft-copy displays are a concern as well as hanging protocols and workstations must be optimized and streamlined for digital mammography reading.
   
Ultimately, Siebert indicated that digital mammography is ready for prime time on a site-by-site basis. Sites in the market should complete a thorough technical evaluation and business and clinical plans prior to making the decision to deploy digital mammography. Key variables in the decision-making process include enterprise buy-in among radiologists, techs, IT staff, physicists and administration. On the technical side, mammography PACS and dedicated workstations are mandatory. Finally, the facility needs to understand quality control issues and government requirements.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Trimed Popup
Trimed Popup